0 results available. Select is focused ,type to refine list, press Down to open the menu,
iTeos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients with cancer. The company’s lead antibody pro...
The following section summarizes insights on Iteos Therapeutics Inc's Ben Graham Formula Upside:
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to Ben Graham Formula Upside in the valuation category include:
The percentage increase (if positive) or decrease (if negative) an investor can expect over the current stock price based on the Ben Graham Formula Va...
Ben Graham Formula Upside is the percentage upside (if positive) or downside (if negative) implied by the current stock price when compared to Fair Value derived using the Ben Graham Formula.
The chart above depicts the distribution of ben graham formula upside for companies operating in the Healthcare sector in the Developed economic region. Over 2,445 companies were considered in this analysis, and 2,401 had meaningful values. The average ben graham formula upside of companies in the sector is -85.2% with a standard deviation of 33.1%.
Iteos Therapeutics Inc's Ben Graham Formula Upside of -100.0% ranks in the 0.0% percentile for the sector. The following table provides additional summary stats:
| Economic Risk Region | Developed |
| Total Constituents | 2,450 |
| Included Constituents | 2,401 |
| Min | -100.0% |
| Max | 86.4% |
| Median | -100.0% |
| Mean | -85.2% |
| Standard Deviation | 33.1% |
You can find companies with similar ben graham formula upside using this stock screener.